A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

Clinical trial NCT04015141 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04015141
Sponsor: Eisai Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pediatric Epileptic Syndrome Partial-onset Seizures

Start date: 2019-05-31
Primary completion: 2027-04-06
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.